论文部分内容阅读
目的探讨小剂量低分子肝素钙在慢性阻塞性肺病中的应用。方法慢性阻塞性肺疾病患者58例随机分为治疗组,对照组。两组患者均给予常规治疗,治疗组加用低分子肝素钙2500u皮下注射,每天注射2次,间隔12h,连续应用10d。观察治疗前后临床症状的变化。结果治疗组33例中,显效22例,有效8例,无效3例,总有效率90.09%。对照组25例中,显效9例,有效8例,无效83例,总有效率68.00%。治疗组总有效率明显高于对照组,差异有统计学意义(P<0.01)。结论小剂量低分子肝素钙在慢性阻塞性肺疾病的治疗中,疗效确切,值得临床推广应用。
Objective To investigate the application of low-dose low molecular weight heparin calcium in chronic obstructive pulmonary disease. Methods 58 patients with chronic obstructive pulmonary disease were randomly divided into treatment group and control group. Two groups of patients were given conventional treatment, the treatment group with low molecular weight heparin 2500u subcutaneous injection, twice daily injection, interval 12h, continuous application of 10d. Changes in clinical symptoms before and after treatment were observed. Results Among the 33 cases in the treatment group, 22 cases were markedly effective, 8 cases were effective, 3 cases were ineffective, and the total effective rate was 90.09%. In control group, 25 cases were markedly effective in 9 cases, effective in 8 cases, ineffective in 83 cases, the total effective rate was 68.00%. The total effective rate of the treatment group was significantly higher than that of the control group, the difference was statistically significant (P <0.01). Conclusion Low dose of low molecular weight heparin in the treatment of chronic obstructive pulmonary disease, the curative effect is exact, worthy of clinical application.